SM is a section editor at Eye Journal
Mnnist, S., Kontto, J., Kataja-Tuomola, M., Albanes, D., & Virtamo, J
Publishing Model: Open Access Deadline: Oct 31, 2026 Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic Landscape Cardiovascular Diabetology features a Collection on "Incretin-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence and the Evolving Cardiometabolic Landscape"
About four in ten adults ages 50 to 64 and 65 and older say they have heard a lot about GLP-1 drugs, compared to about one-third of adults ages 30-49 (32%) and one in six adults ages 18-29 (17%)
This makes titration straightforward but less customizable
Buy Mission Carb Balance this weekend